Rheumatology International

Article	Citations
The global prevalence of rheumatoid arthritis: a meta-analysis based on a systematic review	308
Severe COVID-19, multisystem inflammatory syndrome in children, and Kawasaki disease: immunological mechanisms, clinical manifestations and management	214
SARS-CoV-2 vaccines and autoimmune diseases amidst the COVID-19 crisis	116
Willingness to get the COVID-19 vaccine among patients with rheumatic diseases, healthcare workers and general population in Turkey: a web-based survey	92
ANCA-associated vasculitis after COVID-19	87
Autoimmune and rheumatic musculoskeletal diseases as a consequence of SARS-CoV-2 infection and its treatment	84
High rates of severe disease and death due to SARS-CoV-2 infection in rheumatic disease patients treated with rituximab: a descriptive study	79
Hemophagocytic lymphohistiocytosis: a review inspired by the COVID-19 pandemic	78
Coronavirus disease 2019 (COVID-19) in autoimmune and inflammatory conditions: clinical characteristics of poor outcomes	75
Antibody response to inactivated COVID-19 vaccine (CoronaVac) in immune-mediated diseases: a controlled study among hospital workers and elderly	73
YouTube as a source of information on gout: a quality analysis	69
Postdischarge rheumatic and musculoskeletal symptoms following hospitalization for COVID-19: prospective follow-up by phone interviews	69
The Beighton Score as a measure of generalised joint hypermobility	67
COVID-19 vaccine hesitancy in patients with systemic autoimmune rheumatic disease: an interview-based survey	67
Kawasaki-like disease in children with COVID-19	65
The psychological state and changes in the routine of the patients with rheumatic diseases during the coronavirus disease (COVID-19) outbreak in Turkey: a web-based cross-sectional survey	64
Can the SARS-CoV-2 infection trigger systemic lupus erythematosus? A case-based review	63
Safety of the ChAdOx1 nCoV-19 and the BBV152 vaccines in 724 patients with rheumatic diseases: a post-vaccination cross-sectional survey	58
Comorbidities in psoriatic arthritis: a systematic review and meta-analysis	56
Telemedicine for patients with rheumatic and musculoskeletal diseases during the COVID-19 pandemic; a positive experience in the Netherlands	55
Comorbidities in rheumatic diseases need special consideration during the COVID-19 pandemic	53
Understanding and managing anti-MDA 5 dermatomyositis, including potential COVID-19 mimicry	52
Risk and clinical outcomes of COVID-19 in patients with rheumatic diseases compared with the general population: a systematic review and meta-analysis	52
Multiple system inflammatory syndrome associated with SARS-CoV-2 infection in an adult and an adolescent	47
COVID-19 pandemic in Japan	47

Reactive arthritis after COVID-19: a case-based review	45
ANCA-associated vasculitis following ChAdOx1 nCoV19 vaccination: case-based review	44
Management of childhood-onset autoinflammatory diseases during the COVID-19 pandemic	42
Local and systemic reactogenicity of COVID-19 vaccine BNT162b2 in patients with systemic lupus erythematosus and rheumatoid arthritis	41
The lipid paradox in rheumatoid arthritis: the dark horse of the augmented cardiovascular risk	39
Impact of COVID-19 pandemic on rheumatoid arthritis from a Multi-Centre patient-reported questionnaire survey: influence of gender, rural–urban gap and north–south gradient	38
Adverse events of six COVID-19 vaccines in patients with autoimmune rheumatic diseases: a cross-sectional study	38
COVID-19 vaccination in autoimmune disease (COVAD) survey protocol	37
Teleconsultation experience with the idiopathic inflammatory myopathies: a prospective observational cohort study during the COVID-19 pandemic	34
Benefits and adverse effects of hydroxychloroquine, methotrexate and colchicine: searching for repurposable drug candidates	33
Systemic autoimmune diseases, anti-rheumatic therapies, COVID-19 infection risk and patient outcomes	32
Does immunosuppressive treatment entail an additional risk for children with rheumatic diseases? A survey-based study in the era of COVID-19	32
Immune checkpoint inhibitor-induced musculoskeletal manifestations	32
Implications of COVID-19 in pediatric rheumatology	32
Sex hormones, autoimmunity and gender disparity in COVID-19	31
Use of telemedicine during the COVID-19 pandemic in patients with inflammatory arthritis: a retrospective study on feasibility and impact on patient-reported outcomes in a real-life setting	31
Uric acid extrarenal excretion: the gut microbiome as an evident yet understated factor in gout development	30
The prevalence of fibromyalgia in axial spondyloarthritis	29
Cyclosporine therapy in cytokine storm due to coronavirus disease 2019 (COVID-19)	28
COVID-19 vaccine safety and nocebo-prone associated hesitancy in patients with systemic rheumatic diseases: a cross-sectional study	28
Interferon-gamma release assays outcomes in healthy subjects following BNT162b2 mRNA COVID-19 vaccination	27
Tofacitinib in the treatment of skin and musculoskeletal involvement in patients with systemic sclerosis, evaluated by ultrasound	26
The incidence and prevalence of cardiovascular diseases in gout: a systematic review and meta-analysis	25
Different types of physical activity are positively associated with indicators of mental health and psychological wellbeing in rheumatoid arthritis during COVID-19	25
Rheumatologists’ practice during the Coronavirus disease 2019 (COVID-19) pandemic: a survey in Egypt	25
Public interest in rheumatic diseases and rheumatologist in the United States during the COVID-19 pandemic: evidence from Google Trends	25
Cardiovascular risk assessment in patients with rheumatoid arthritis using carotid ultrasound B-mode imaging	24
Coronavirus disease 2019 (COVID-19) in a patient with ankylosing spondylitis treated with secukinumab: a case-based review	24
Statistical data presentation: a primer for rheumatology researchers	23
Corticosteroid monotherapy for the management of Takayasu arteritis—a systematic review and meta-analysis	23
Are patients with hypermobile Ehlers–Danlos syndrome or hypermobility spectrum disorder so different?	22
Use of rituximab and the risk of adverse clinical outcomes in COVID-19 patients with systemic rheumatic disease	22
Increased risk of mental health disorders in patients with RA during the COVID-19 pandemic: a possible surge and solutions	21
Does methotrexate cause progressive fibrotic interstitial lung disease? A systematic review	21
Prevalence of osteoarthritis in lower middle- and low-income countries: a systematic review and meta-analysis	21
Measurement of sedentary time and physical activity in rheumatoid arthritis: an ActiGraph and activPAL™ validation study	20
Systemic toxicity of chloroquine and hydroxychloroquine: prevalence, mechanisms, risk factors, prognostic and screening possibilities	20
Short-term outcomes in children recovered from multisystem inflammatory syndrome associated with SARS-CoV-2 infection	20
Post-publication promotion in rheumatology: a survey focusing on social media	19
Trends in idiopathic inflammatory myopathies: cross-sectional data from the German National Database	19
The effect of anti-TNF treatment on body composition and insulin resistance in patients with rheumatoid arthritis	19
Osteoporosis in patients with rheumatoid arthritis: trends in the German National Database 2007–2017	19
Cardiovascular disease detection using machine learning and carotid/femoral arterial imaging frameworks in rheumatoid arthritis patients	19
Rheumatology university faculty opinion on coronavirus disease-19 (COVID-19) vaccines: the vaXurvey study from Egypt	19
Scholarly publishing and journal targeting in the time of the Coronavirus Disease 2019 (COVID-19) pandemic: a cross-sectional survey of rheumatologists and other specialists	19
Publication activity in the field of Sjögren’s syndrome: a ten-year Web of Science based analysis	19
Granulomatous mastitis, erythema nodosum and arthritis syndrome: case-based review	18
Monogenic lupus due to spondyloenchondrodysplasia with spastic paraparesis and intracranial calcification: case-based review	18
Clinical characteristics and outcome of COVID-19 in patients with rheumatic diseases	18
Tele-health interventions to support self-management in adults with rheumatoid arthritis: a systematic review	18

Impact of COVID-19 pandemic on patients with rheumatic diseases in Latin America	17
Platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio as potential makers for digital ulcers and interstitial lung disease in patients with systemic sclerosis: cross-sectional analysis of da	17
The effectiveness and safety of electrotherapy in the management of fibromyalgia	17
Outcomes of multisystem inflammatory syndrome in children temporally related to COVID-19: a longitudinal study	17
YouTube videos as a source of information concerning Behçet’s disease: a reliability and quality analysis	17
A flare of Still’s disease following COVID-19 vaccination in a 34-year-old patient	17
Treatment of refractory adult onset Still’s disease with tocilizumab—a single centre experience and literature review	17
Pain is not the major determinant of quality of life in fibromyalgia: results from a retrospective “real world” data analysis of fibromyalgia patients	17
The clinical course of SARS-CoV-2 infection among children with rheumatic disease under biologic therapy: a retrospective and multicenter study	16
YouTube as a source of information on COVID-19 vaccination in rheumatic diseases	16
Clinical performance of ASAS Health Index in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis: real-world evidence from Multicenter Nationwide Registry	16
Ankylosing spondylitis rehabilitation publications and the global productivity: a Web of Science-based bibliometric analysis (2000–2019)	16
Rheumatoid factor and falsely elevated results in commercial immunoassays: data from an early arthritis cohort	15
Increased influenza vaccination rates in patients with autoimmune rheumatic diseases during the Covid-19 pandemic: a cross-sectional study	15
Revisiting the JOQUER trial: stratification of primary Sjögren’s syndrome and the clinical and interferon response to hydroxychloroquine	15
The importance of heart and brain imaging in children and adolescents with Multisystem Inflammatory Syndrome in Children (MIS-C)	15
Contribution of Arab Countries to Familial Mediterranean Fever Research: a PubMed-based bibliometric analysis	15
Why do some people with severe chronic pain adhere to walking prescriptions whilst others won’t? A cross-sectional study exploring clinical and psychosocial predictors in women with fibromyalgia	15
Incidence, prevalence and mortality of systemic sclerosis in Italy: a nationwide population-based study using administrative health data	15
The relationship between cervical proprioception and balance in patients with fibromyalgia syndrome	15
Expanding the spectrum of reactive arthritis (ReA): classic ReA and infection-related arthritis including poststreptococcal ReA, Poncet’s disease, and iBCG-induced ReA	14
Barriers to medication adherence and degree of nonadherence in a systemic lupus erythematosus (SLE) outpatient population	14
Comparative risk of infections among real-world users of biologics for juvenile idiopathic arthritis: data from the German BIKER registry	14
Prevalence and clinical significance of antiphospholipid antibodies in patients with coronavirus disease 2019 admitted to intensive care units: a prospective observational study	14
Rituximab-associated hypogammaglobulinemia in autoimmune rheumatic diseases: a single-center retrospective cohort study	14
Protracted severe COVID-19 pneumonia following rituximab treatment: caution needed	14
The influence of perioperative interventions targeting psychological distress on clinical outcome after total knee arthroplasty	14
‘But you don’t look sick’: a qualitative analysis of the LUPUS UK online forum	14
Targeted high concentration botulinum toxin A injections in patients with Raynaud’s phenomenon: a retrospective single-centre experience	14
Epidemiology and genetics of granulomatosis with polyangiitis	14
Patient self-sampling: a cornerstone of future rheumatology care?	13
Analysis of a single-institution cohort of patients with Felty's syndrome and T-cell large granular lymphocytic leukemia in the setting of rheumatoid arthritis	13
Self-limiting COVID‐19-associated Kikuchi‐Fujimoto disease with heart involvement: case-based review	13
The feasibility of an exercise intervention to improve sleep (time, quality and disturbance) in people with rheumatoid arthritis: a pilot RCT	13
#Covid4Rheum: an analytical twitter study in the time of the COVID-19 pandemic	13
Safety and efficacy of COVID-19 vaccines in pregnant women with rheumatic diseases: an immunologic perspective	13
Characteristics and outcomes of overlap myositis: a comparative multigroup cohort study in adults from the MyoCite cohort	13
Psychosocial and clinical effects of the COVID-19 pandemic in patients with childhood rheumatic diseases and their parents	13
Effects of the SARS-CoV-2 global pandemic on U.S. rheumatology outpatient care delivery and use of telemedicine: an analysis of data from the RISE registry	13
Impact of the COVID-19 pandemic on the frequency of the pediatric rheumatic diseases	12
Assessment of sarcopenia in patients with fibromyalgia	12
Rehabilitative management of post-acute COVID-19: clinical pictures and outcomes	12
Comparison of the efficacy and safety of biologic agents between elderly-onset and young-onset RA patients: the ANSWER cohort study	12
Macrophage activation syndrome in systemic lupus erythematosus and systemic-onset juvenile idiopathic arthritis: a retrospective study of similarities and dissimilarities	12
Mental health and quality of life for people with rheumatoid arthritis or ankylosing spondylitis in Aotearoa New Zealand following the COVID-19 national lockdown	12
Differential approach to peripheral blood cell ratios in patients with systemic lupus erythematosus and various manifestations	12
Carpal tunnel syndrome in patients with rheumatoid arthritis and psoriatic arthritis: an electrophysiological and ultrasonographic study	12
Bibliometric analysis of publication activity in the field of familial Mediterranean fever in 2010–2019: a Scopus-based study	12
Is exposure to environmental factors associated with a characteristic clinical and laboratory profile in systemic sclerosis? A retrospective analysis	12
Development and initial validation of a questionnaire to assess facilitators and barriers to physical activity for patients with rheumatoid arthritis, axial spondyloarthritis and/or psoriatic arthriti	12
Cytokines and chemokines multiplex analysis in patients with low disease activity rheumatoid arthritis	12
The structural, functional and electrophysiological assessment of paraspinal musculature of patients with ankylosing spondylitis and non-radiographic axial spondyloarthropathy	12
The prevalence and impact of depression in primary systemic vasculitis: a systematic review and meta-analysis	12
Classification of ANCA-associated vasculitis: differences based on ANCA specificity and clinicopathologic phenotype	12
COVID-19 outcomes in patients with familial Mediterranean fever: a retrospective cohort study	11
Association of rheumatoid arthritis with hearing loss: a systematic review and meta-analysis	11
The impact of COVID-19 on rheumatology patients in a large UK centre using an innovative data collection technique: prevalence and effect of social shielding	11
Pulmonary involvement in systemic sclerosis: exploring cellular, genetic and epigenetic mechanisms	11
Clinical and pathological characteristics of ANA/anti-dsDNA positive patients with antineutrophil cytoplasmic autoantibody-associated vasculitis	11
The accuracy of administrative health data for identifying patients with rheumatoid arthritis: a retrospective validation study using medical records in Western Australia	11
Proposal of a new nomenclature for the underlying pathogenetic mechanism of severe Coronavirus Disease-19: “Inflammatory Thrombosis with Immune Endotheliitis—ITIE”	10
COVID-19 in patients with gout on colchicine	10
Indian SLE Inception cohort for Research (INSPIRE): the design of a multi-institutional cohort	10
COVID-19 pneumonia in a patient with granulomatosis with polyangiitis on rituximab: case-based review	10
Clinical and cost-effectiveness of physiotherapy interventions following total hip replacement: a systematic review and meta-analysis	10
Low-dose rituximab therapy in steroid-refractory thrombocytopenia due to systemic lupus erythematosus	10
Early-onset subclinical cardiovascular damage assessed by non-invasive methods in children with Juvenile Idiopathic Arthritis: analytical cross-sectional study	10
Secondary consequences of juvenile idiopathic arthritis in children and adolescents with knee involvement: physical activity, adiposity, fitness, and functional performance	10
The association between alcohol consumption and osteoarthritis: a meta-analysis and meta-regression of observational studies	10
Validity and reliability of the Patient Health Questionnaire-8 in Swedish for individuals with systemic sclerosis	10
Tocilizumab therapy in juvenile systemic sclerosis: a retrospective single centre pilot study	10
The impact of COVID-19 on familial Mediterranean fever: a nationwide study	9
Enhancing rheumatology education during the COVID-19 pandemic	9
Methotrexate does not increase the risk of liver fibrosis in patients with rheumatoid arthritis: assessment by ultrasound elastography (ARFI-MetRA study)	9
The impact of fatigue on patients with psoriatic arthritis: a multi-center study of the TLAR-network	9
Sneddon syndrome: under diagnosed disease, complex clinical manifestations and challenging diagnosis. A case-based review	9
Nurse-led care for the management of rheumatoid arthritis: a review of the global literature and proposed strategies for implementation in Africa and the Middle East	9
Subclinical atherosclerosis in systemic sclerosis and rheumatoid arthritis: a comparative matched-cohort study	9
Pain catastrophizing in rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis: biopsychosocial perspective and impact on health-related quality of life	9
Are YouTube videos enough to learn anakinra self-injection?	9

Persistence on biologic DMARD monotherapy after achieving rheumatoid arthritis disease control on combination therapy: retrospective analysis of corrona registry data	9
Vascular endothelial injury assessed with functional techniques in systemic sclerosis patients with pulmonary arterial hypertension versus systemic sclerosis patients without pulmonary arterial hypert	9
Emerging epigenetic targets in rheumatoid arthritis	9
Cardiac involvement in primary Sjӧgren’s syndrome	9
Sequence analysis in Familial Mediterranean Fever patients with no confirmatory genotype	8
Telehealth in rheumatology: the 2021 Arab League of Rheumatology Best Practice Guidelines	8
IgA nephropathy with serum ANCA positivity: case series and literature review	8
Impact of obesity on quality of life, psychological status, and disease activity in psoriatic arthritis: a multi‑center study	8
Self-care recommendations for patients with rheumatic diseases during the COVID-19 pandemic	8
Clinical spectrum of active tuberculosis in patients with systemic lupus erythematosus	8
Adequately dosed aerobic physical activity in people with axial spondyloarthritis: associations with physical therapy	8
Demographic and clinical characteristics of patients with ANCA-positive vasculitis in a Colombian University Hospital over a 12-year period: 2005–2017	8
Dosage of resistance exercises in fibromyalgia: evidence synthesis for a systematic literature review up-date and meta-analysis	8
COVID-19 from a rheumatology perspective: bibliometric and altmetric analysis	8
Systemic lupus erythematosus complicated with Castleman disease: a case-based review	8
Glucocorticoid maintenance therapy and severe infectious complications in ANCA-associated vasculitis: a retrospective analysis	8
A retrospective comparison of respiratory events with JAK inhibitors or rituximab for rheumatoid arthritis in patients with pulmonary disease	8
Renal dysfunction in systemic sclerosis beyond scleroderma renal crisis	8
Effect of n-3 PUFA on extracellular matrix protein turnover in patients with psoriatic arthritis: a randomized, double-blind, placebo-controlled trial	8
IgA immunoglobulin isotype of rheumatoid factor in primary Sjögren’s syndrome	7
Antibody subtypes and titers predict clinical outcomes in ANCA-associated vasculitis	7
Post-COVID-19 exacerbation of fibrodysplasia ossificans progressiva with multiple flare-ups and extensive heterotopic ossification in a 45-year-old female patient	7
Prevalence of large vessel vasculitis in ANCA-associated vasculitis: a retrospective cohort study	7
Pharmacological treatment for managing bone health in axial spondyloarthropathy: systematic review and meta-analysis	7
Adrenocorticotropic hormone: an effective “natural” biologic therapy for acute gout?	7
Increased prevalence rate of metabolic syndrome is an independent predictor of cardiovascular disease in patients with antineutrophil cytoplasmic antibody-associated vasculitis	7
Spinal involvement in juvenile idiopathic arthritis: what do we miss without imaging?	7
miR-19b-3p and miR-20a-5p are associated with the levels of antiphospholipid antibodies in patients with antiphospholipid syndrome	7
Clinical characteristics of patients with myalgia as the initial manifestation of small and medium-sized vasculitis: a retrospective study	7
Inflammatory milieu of muscle biopsies in juvenile dermatomyositis	7
Participation in physical activity decreased more in people with rheumatoid arthritis than the general population during the COVID-19 lockdown: a cross-sectional study	7
Management of pediatric rheumatic patients in Kazakhstan during the coronavirus disease 2019 (COVID-19) pandemic	7
Reduction of biologics in rheumatoid arthritis: a systematic review and meta-analysis	7
Disease activity and patient-reported outcomes in patients with rheumatoid arthritis and Sjögren’s syndrome enrolled in a large observational US registry	7
Back pain, ankylosing spondylitis and social media usage; a descriptive analysis of current activity	7
Ultrasound-guided genicular nerve block versus physical therapy for chronic knee osteoarthritis: a prospective randomised study	7
The role of IL-17 rs2275913, IL-17RC rs708567 and TGFB1 rs1800469 SNPs and IL-17A serum levels in patients with lupus nephritis	7
Use of conventional synthetic and biologic disease-modifying anti-rheumatic drugs in patients with rheumatic diseases contracting COVID-19: a single-center experience	7
Challenges in diagnosis of limited granulomatosis with polyangiitis	7
COVID-19 in patients with familial Mediterranean fever treated with colchicine: case based review	7
Severe infections in patients with anti-neutrophil cytoplasmic antibody-associated vasculitis: a retrospective cohort study with a clinical phenotype approach	7
Colchicine as an adjunct to heparin for prophylaxis of venous thromboembolism in patients with COVID-19	7
Coincidence of juvenile idiopathic arthritis and type 1 diabetes: a case-based review	7
New lung mass in a patient with granulomatosis with polyangiitis	7
Canakinumab is effective in patients with familial Mediterranean fever resistant and intolerant to the colchicine and/or anakinra treatment	7
Sexual dysfunction and depression in Behçet’s disease in comparison to healthy controls	6
Association of polymorphisms in promoter region of TNF-α -238 and -308 with clinical outcomes in patients with immune-mediated inflammatory diseases on anti-TNF therapy	6
COVID-19 and eosinophilic granulomatosis with polyangiitis or COVID-19 mimicking eosinophilic granulomatosis with polyangiitis?	6
Evaluating standards of care in psoriatic arthritis of the QUANTUM project (qualitative initiative to improve outcomes): results of an accreditation project in Spain	6
Effectiveness of reproductive health counseling of women with systemic lupus erythematosus: observational cross-sectional study at an academic lupus clinic	6
Poor maternal and foetal outcomes in women with systemic sclerosis: an interview-based study at a tertiary centre	6
High-resolution ultrasound imaging of skin involvement in systemic sclerosis: a systematic review	6
A real-world assessment of mycophenolate mofetil for remission induction in eosinophilic granulomatosis with polyangiitis	6
Risk factors for the progression of finger interphalangeal joint osteoarthritis: a systematic review	6
Interstitial lung disease with myeloperoxidase-antineutrophil cytoplasmic antibody-associated vasculitis in elderly patients	6
Improving the quality of life of patients with rheumatoid arthritis after rehabilitation irrespective of the level of disease activity	6
Assessment of the responsiveness of four scales in geriatric patients with chronic neck pain	6
Faster age-related decline in cardiorespiratory fitness in rheumatoid arthritis patients: an observational study in the Trøndelag Health Study	6
Insights into the knowledge, attitude and practices for the treatment of idiopathic inflammatory myopathy from a cross-sectional cohort survey of physicians	6
Is it possible to not perform salivary gland biopsy in targeted patients according to unstimulated salivary flow results in patients with suspected Sjögren's syndrome?	6
Coronavirus disease 2019 (COVID-19) during pregnancy in patients with rheumatic diseases	6
French survey on the crossed needs on sexual health for chronic inflammatory rheumatism patients and healthcare professionals	6
Bibliometric analysis of the global literature productivity of adult-onset Still’s disease (2011–2020)	6
Autoimmune syndrome induced by adjuvants after breast enhancement with polyacrylamide hydrogel: a study in Poland	6
Apoptosis and secondary necrosis of neutrophils and monocytes in the immunopathogenesis of rheumatoid arthritis: a cohort study	6
COVID-19 and fertility—at the crossroads of autoimmunity and thrombosis	6
Multimodal approach to intraarticular drug delivery in knee osteoarthritis	6
Evaluation of Big Five personality factors in women with fibromyalgia: a cross-sectional study	6
The incidence, clinical characteristics, and outcome of COVID-19 in a prospectively followed cohort of patients with Behçet’s syndrome	6
Syndrome of progressive deforming non-inflammatory arthritis of childhood: two patients of camptodactyly-arthropathy-coxa vara-pericarditis syndrome	6